http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2354451-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-662 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate | 1999-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6930e548e4e28d211c25b16d9472487 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f617a9d27ed7d4764372dcfdbfe352a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_680b4963d84cf21bee97b24c70f30a15 |
| publicationDate | 2000-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2354451-A1 |
| titleOfInvention | Halovir, an antiviral marine natural product, and derivatives thereof |
| abstract | The present invention provides a compound having the structure (I) wherein Rla and R1b are independently selected from the group consisting of -H, alkyl, lower-alkyl, substituted alkyl and substituted lower-alkyl; R2a and R2b are independently selected from the group consisting of -H, lower-alkyl, and substituted lower-alkyl; R3 is -H, lower-alkyl, substituted lower-alkyl and where R3 and R4 are attached together by a lower-alkyl or a substituted lower-alkyl moiety; R4 is -H, lower-alkyl, substituted lower-alkyl and where R3 and R4 are attached together form a lower-alkyl or substituted lower-alkyl bridge; R5, R7, R9 and R11 are independently selected from the group consisting of -H, lower-alkyl, and substituted lower-alkyl; R6 is -H, lower-alkyl and substituted lower-alkyl; R8 is -H, lower-alkyl and substituted lower-alkyl; R10 is -H, lower-alkyl and substituted lower-alkyl; R12 is -H, lower-alkyl and substituted lower-alkyl; and A is -C(O)-R13, wherein R13 is -H, -OH, alkyl, lower-alkyl, substituted lower-alkyl or -O(lower-alkyl); -CH2-OR14 wherein R14 is -H, -C(O)CH3, alkyl, lower-alkyl or substituted lower-alkyl; or -CH2-NR15R16, where R15 and R16 are independently selected from -H, lower-alkyl, alkyl, substituted lower-alkyl or substituted alkyl; a pharmaceutically acceptable salt or derivatives thereof, useful for preventing or treating viral and microbial infections. |
| priorityDate | 1998-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 131.